Dear Readers, 

 

The knowledge on SARS-CoV-2 and COVID-19 is growing rapidly because of massive R&D efforts around the globe. We now know more about the characteristics of superspreading events, and measures to cut back virus transmission for example. Many of the news items included in today’s newsletter are linked to the pandemic. The news archive on our website provides a broader overview.

Of course, much more needs to be done and we are happy to see a growing number of concerted actions internationally, involving Austria’s academic and business community. Recently, the European Commission has mobilized an additional € 122 million for SARS-CoV-2 research and innovation to boost Europe’s contribution to the global response to the pandemic.

To contribute to the development of coronavirus tests and in-vitro diagnostics, we are organizing a webinar in collaboration with BBMRI.at and en.co.tec focusing on legal issues. Save the date for June 5, 2020 to learn more about CE-marks and to avoid common mistakes. 

We encourage you to remain cautious and to protect yourself and the people you interact with. The next wave of infection might hit your surrounding sooner than expected. Until then, soak up some sun and culture when having time off.

Yours,
LISAvienna

Twitter
LinkedIn
Website

Are you up to date?

Vienna's growing life sciences community is continuously announcing important business highlights and outstanding research on SARS-CoV-2 and COVID-19.

We are happy to share a selection of recent news items with you.



26.5.2020


22.5.2020


18.5.2020

14.5.2020

14.5..2020

12.5.2020

12.5.2020

11.5.2020

8.5.2020



4.5.2020
The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve their care quality level according to an economic and financial sustainability approach, announces that it has completed the acquisition of part of Agfa HealthCare (Agfa-Gevaert Group) IT business for the healthcare sector.
ALL NEWS ➜

Focusing on LISAvienna

We support innovative life sciences companies in Vienna that are developing and marketing new products, services and processes.
Learn more about our activities here.

Save the date: 6.5.2020
Webinar: Die CE-Kennzeichnung als ausreichendes Gütesiegel von IVD Tests?
BBMRI.at, en.co.tec & LISAvienna
COVID-19: Research, products and services in Austria
SARS-CoV-2: Relief Efforts and Funding Opportunities

NEW: Additional € 122 million for SARS-CoV-2 research and innovation provided by the European Commission - apply by June 11!

Upcoming events

We look forward to meeting you at events later this year.
For now, please consider participating in virtual events and advanced training opportunities. 

Please get in touch with us to arrange a digital meeting!

Online meetings and workshops

27.5.2020

FFG Webinar: Neuerungen in den Basisprogrammen - Kleinprojekt und Collective Research

28.5.2020

GPMed: BASG Gespräch – Klinische Prüfungen in Zeiten der COVID-19 Pandemie

28.5.2020

ABA's Virtual Open Day
Insights into Austria’s specific competitive advantages as a business, research, life sciences, holding and start-up location

4.6.2020

anapur: DATA MEETS GXP
Two free tickets are available for this online Workshop. Declare you interest by May 27, 2020.
ALL EVENTS ➜

Funding and support

Securing sufficient funding at the right time is a prerequisite to the success of every life sciences company.
LISAvienna's owners and network partners offer great opportunities for support in this regard.

Contact us for a personalized virtual consultation on funding and support opportunities!

Open calls and deadlines

29.5.2020 / 30.6.2020
Vienna Business Agency - Innovate4Vienna

1.6.2020
COVIDathon

11.6.2020
H2020 COVID-19 Calls

Batch review, call open until 30.6.2020
CEPI - Vaccines against COVID-19
ALL OPEN CALLS AND DEADLINES ➜
Apply at any time
aws PreSeed
up to € 200,000 grant for proof-of-principle / proof-of-concept studies of high-tech start-up projects in Austria
aws Seedfinancing
up to € 800,000 conditionally repayable contribution for founding high-tech businesses in Austria
aws Protecting Innovation
up to € 200,000 grant for SMEs in Austria that want to develop and implement am indivudual IP strategy
FFG General Programs
up to € 3 million for R&D projects to develop commercially viable products, processes and services in Austria
OTHER FUNDING OPPORTUNITIES ➜

Life sciences in Vienna

Are you familiar with the key facts and figures on biotechnology, the pharmaceutical industry and the medical device business sector in Vienna, the world's most livable city?

MORE INFORMATION ➜
Twitter
LinkedIn
Website
Copyright © 2020 LISAvienna, All rights reserved.

Our mailing address is: office@LISAvienna.at

LISAvienna is a joint life science platform operated by austria wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna, LISAvienna contributes to the advancement of life sciences in Vienna.

Our news review, our outlook on future events and our list of opportunities for funding and support are not exhaustive and LISAvienna accepts no liability for potential mistakes.

update your preferences | unsubscribe from this list.